JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2002, 51(5):226-235

Progress in Antifungal Drugs Development

M. Doležal
Katedra farmaceutické chemie a kontroly léčiv Farmaceutické fakulty Univerzity Karlovy, Hradec Králové

The present review paper deals with novel antifungal drugs. The lack of new antifungal drugsascends proportionally to the increasing occurrence of serious infections caused by yeast and fungimainly at immunocompromised or in other way sensitive patients. The topical state of pharmacotherapyis briefly drawn out; most attention is given to newly developed active entities. Establishedagents do not satisfy the medical need completely, azoles are fungistatic and vulnerable to resistance,whereas polyenes cause serious host toxicity. Drugs in clinical development include modified azolesand a new class of echinocandins and pneumocandins. Other promising novel agents in preclinicaldevelopment include several inhibitors of fungal protein, lipid and cell wall syntheses.

Keywords: antimycotics; polyens; azols; echinocandins; sordarins

Published: May 1, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doležal M. Progress in Antifungal Drugs Development. Čes. slov. farm. 2002;51(5):226-235.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)

    • Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.